Physician
Solano Hematology - Oncology
Solano Hematology - Oncology was paid $7.85M by Medicaid between Jan 2018 and Oct 2024, across 65 billing codes. Its largest line is J9271, Injection, pembrolizumab, 1 mg — 21% of everything it billed.
33Billing provider infoSOLANO HEMATOLOGY - ONCOLOGY
VALLEJO, CA 94589
VALLEJO, CA 94589
33aNPI1528399193assigned 01/21/2010
33bProvider typeHematology & Oncology Physician
28Total paid$7.85M
24GClaims262,992
24DCodes billed65
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in California
Rank by total paid#3 of 180
Median peer was paid$26K
This provider vs. median305×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,084 | $667K | |
| 2019 | 36,978 | $878K | |
| 2020 | 41,046 | $998K | |
| 2021 | 41,546 | $1.31M | |
| 2022 | 40,104 | $1.92M | |
| 2023 | 43,200 | $1.44M | |
| 2024incomplete | 28,034 | $639K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 21% | 288 | 225 | $1.65M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 34,263 | 20,074 | $1.40M |
| 96375 | Therapeutic injection; each additional sequential IV push | 11% | 15,768 | 6,120 | $888K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 8.8% | 7,634 | 3,593 | $689K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 8.4% | 9,441 | 3,916 | $656K |
| P9046 | Infusion, albumin (human), 25%, 20 ml | 4.0% | 2,892 | 1,071 | $314K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.6% | 14,052 | 10,259 | $286K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.6% | 4,327 | 3,252 | $280K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.5% | 3,136 | 1,647 | $194K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.2% | 31,318 | 18,549 | $176K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2.1% | 5,385 | 3,176 | $166K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.0% | 25,552 | 15,790 | $154K |
53 more codes
| J7030 | Infusion, normal saline solution , 1000 cc | 1.8% | 12,340 | $142K |
| 96367 | 1.8% | 3,576 | $141K | |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | <1% | 302 | $68K |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 2,533 | $67K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,224 | $49K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 9,039 | $49K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 5,036 | $44K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,470 | $41K |
| 96415 | <1% | 768 | $35K | |
| J2780 | Injection, ranitidine hydrochloride, 25 mg | <1% | 3,723 | $34K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,366 | $32K |
| J0897 | Injection, denosumab, 1 mg | <1% | 64 | $31K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 8,941 | $29K |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 6,015 | $28K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | <1% | 95 | $28K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 4,653 | $22K |
| 96417 | <1% | 372 | $20K | |
| J1453 | Injection, fosaprepitant, 1 mg | <1% | 191 | $18K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 327 | $18K |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | <1% | 3,843 | $17K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 4,432 | $14K |
| 99245 | <1% | 59 | $11K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 209 | $10K |
| Q5122 | Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | <1% | 15 | $10K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,182 | $7K |
| S0028 | Injection, famotidine, 20 mg | <1% | 1,145 | $6K |
| 96411 | <1% | 139 | $4K | |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | <1% | 33 | $3K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,532 | $3K |
| J0640 | Injection, leucovorin calcium, per 50 mg | <1% | 26 | $993.16 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 423 | $975.06 |
| 80076 | <1% | 6,674 | $681.11 | |
| J3490 | Unclassified drugs | <1% | 1,083 | $667.18 |
| 82728 | <1% | 2,925 | $608.71 | |
| 83735 | <1% | 3,954 | $484.92 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 19 | $477.15 |
| 85610 | <1% | 170 | $361.86 | |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 27 | $357.82 |
| 96523 | <1% | 17 | $336.86 | |
| 80053 | Comprehensive metabolic panel | <1% | 685 | $276.87 |
| 83615 | <1% | 2,994 | $270.19 | |
| 82607 | <1% | 1,054 | $240.64 | |
| 82378 | <1% | 415 | $200.05 | |
| 82746 | <1% | 1,206 | $199.59 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 27 | $136.69 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 22 | $58.85 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 315 | $49.63 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 50 | $30.27 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 30 | $25.44 |
| 86140 | <1% | 118 | $13.50 | |
| 84439 | <1% | 178 | $13.24 | |
| 99000 | 0% | 9,146 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 2,754 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLIMVARAPUSS, CHAINARONG (CEO)